Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,310.00
Bid: 12,308.00
Ask: 12,312.00
Change: 192.00 (1.58%)
Spread: 4.00 (0.032%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-Biden to send 20 mln doses of U.S.-authorized vaccines abroad for first time

Mon, 17th May 2021 18:00

(Adds China's comments, vaccine export)

By Steve Holland

WASHINGTON, May 17 (Reuters) - President Joe Biden will send
at least 20 million more COVID-19 vaccine doses abroad by the
end of June, marking the first time the United States is sharing
vaccines authorized for domestic use.

The move marks a notable pivot from the White House as the
administration seeks to use the country's vaccine supply as a
diplomatic tool with the pandemic outlook brightening at home.

Biden announced on Monday that his administration will send
doses of the Pfizer Inc/BioNTech SE, Moderna
Inc and Johnson & Johnson vaccines, on top of
60 million AstraZeneca Plc doses he had already planned
to give to other countries.

Unlike the others, AstraZeneca's shot is not yet authorized
for use in the United States.

"Just as in World War Two America was the arsenal of
democracy, in the battle against COVID-19 pandemic our nation is
going to be the arsenal of vaccines," Biden said.

The president has been under pressure to share vaccines to
help contain worsening epidemics from India to Brazil, where
health experts fear new, more contagious coronavirus variants
could undermine the effectiveness of available shots.

Biden noted that no other country will send more vaccines
abroad than the United States. So far, the United Stages has
sent a few million AstraZeneca doses to Canada and Mexico.

"We want to lead the world with our values with this
demonstration of our innovation, ingenuity, and the fundamental
decency of American people," Biden said.

China, which has exported hundreds of millions of doses
mainly to developing countries and pledged to donate at least
nearly 4 million doses, said it welcomed the U.S. move but it
would not use vaccines as a tool in diplomatic relations.

"We welcome if the U.S. can implement its commitment to
vaccine assistance at an early date and provide tangible help to
developing countries in their fight against the epidemic," Zhao
Lijian, a spokesman at China's foreign ministry, said.

"Unlike the United States, China will not use vaccine
influence to lead the world and will not chant empty slogans
without action," he said at a regular briefing on Tuesday.

The White House has not provided any details about what
countries will receive the shots. Biden said that Jeff Zients,
who heads the U.S. vaccine efforts, will now also lead the
global vaccine push.

The United States has administered more than 272 million
COVID-19 vaccine doses and distributed more than 340 million,
according to federal data updated on Monday morning.

With more and more Americans vaccinated, U.S. deaths from
COVID-19 last week fell to their lowest in nearly 14 months,
while the number of new cases declined for a fifth consecutive
week, according to a Reuters analysis of state and county data.

Biden warned that those who do not get vaccinated "will end
up paying the price" as he lamented that "we're still losing too
many Americans" despite the significant progress.

(Reporting By Steve Holland, Carl O'Donnell and Jarrett
Renshaw; Additional reporting by Beijing Newsroom; Writing by
Jarrett Renshaw; Editing by Trevor Hunnicutt, Bill Berkrot and
Andrew Heavens)

More News
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.